Sector Chart KMPHARMACEUTICAL Co.,Ltd.

Equities

End-of-day quote Korea S.E. Other stock markets 23:00:00 11/06/2024 BST			5-day change	1st Jan Change
820 ^KRW	+1.36%		-0.73%	-16.16%

2018	Km Pharmaceutical Co., Ltd. completed the acquisition of IBKS No.3 Special Purpose Acquisition Company in a reverse merger transaction.	CI
2018	IBKS No.3 Special Purpose Acquisition Company‘s Equity Buyback announced on March 1, 2018, has expired.	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes